Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Effectiveness of Speech Therapy for Lip-reading in Patients With Hearing Aids: SCED Study

NCT07028658 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-10-16
Last updated
2026-04-03

Condition(s) studied

Hearing Loss, Bilateral or Unilateral

Investigational drug(s) / intervention(s)

Speechreading training

Speechreading training: The patient will undergo 16 lip reading training sessions. By developing functional lip reading skills, they will be able to fill in the gaps in auditory information they miss, especially in loud or noisy settings

Study summary

This study aims to investigate whether lip reading rehabilitation improves viseme recognition in individuals with hearing impairments who use hearing aids.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient aged 18 or older * Affiliated with a social security system * Moderate to severe bilateral post-lingual hearing loss, fitted with hearing aids for more than 6 months * Wearing hearing aids for a minimum of 8 hours/day on average over the past month * Intelligibility in quiet \> 80% correct responses at 60 dB (Lafon cochlear list) * Difficulty in noisy environments rated \> 6 on a 0-10 EVA scale * French language comprehension level of at least B1 CEFR (Common European Framework of Reference for Languages) * Willing to participate in speech therapy rehabilitation at a rate of 2 sessions per week Exclusion Criteria: * Patient who has already undergone speech therapy rehabilitation as part of their hearing loss treatment * Diagnosis of neurodegenerative disease or history of brain injury (traumatic brain injury, stroke, tumor, meningitis, etc.) * Uncorrected vision or visual impairment affecting lip reading (e.g. AMD, glaucoma, unoperated cataract, etc.) * Presence of severe tinnitus (score \> 56) on the Tinnitus Handicap Inventory (THI) questionnaire * Significant cognitive impairment (CODEX C or D) or Montreal Cognitive Assessment (MOCA) score \< 23

Primary outcome measure(s)

  • Repetition score, in words (with and without labial doppelganger) of Lafon's cochlear lists presented on video support in visual-only modality — 26 sessions (4,5 months)
  • Repetition score, in visemes (with and without labial doppelganger) of Lafon's cochlear lists presented on video support in visual-only modality — 26 sessions (4,5 months)

Trial sites (1)

FacilityCityRegionStatus
Cabinet d'orthophonie Paris France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07028658 on ClinicalTrials.gov ↗ ← All trials in France